These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Incidence of anal cytological abnormalities in a cohort of human immunodeficiency virus-infected women. Durante AJ, Williams AB, Da Costa M, Darragh TM, Khoshnood K, Palefsky JM. Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):638-42. PubMed ID: 12869403 [Abstract] [Full Text] [Related]
5. Anal cytological abnormalities and anal HPV infection in men with Centers for Disease Control group IV HIV disease. Palefsky JM, Holly EA, Ralston ML, Arthur SP, Hogeboom CJ, Darragh TM. Genitourin Med; 1997 Jun; 73(3):174-80. PubMed ID: 9306896 [Abstract] [Full Text] [Related]
6. High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Piketty C, Darragh TM, Da Costa M, Bruneval P, Heard I, Kazatchkine MD, Palefsky JM. Ann Intern Med; 2003 Mar 18; 138(6):453-9. PubMed ID: 12639077 [Abstract] [Full Text] [Related]
8. Anal human papillomavirus (HPV) prevalences and factors associated with abnormal anal cytology in HIV-infected women in an urban cohort from Rio de Janeiro, Brazil. Cambou MC, Luz PM, Lake JE, Levi JE, Coutinho JR, de Andrade A, Heinke T, Derrico M, Veloso VG, Friedman RK, Grinsztejn B. AIDS Patient Care STDS; 2015 Jan 18; 29(1):4-12. PubMed ID: 25361401 [Abstract] [Full Text] [Related]
9. Prevalence and risk factors for anal squamous intraepithelial lesions in women. Holly EA, Ralston ML, Darragh TM, Greenblatt RM, Jay N, Palefsky JM. J Natl Cancer Inst; 2001 Jun 06; 93(11):843-9. PubMed ID: 11390533 [Abstract] [Full Text] [Related]
12. Incident anal human papillomavirus and human papillomavirus-related sequelae in HIV-infected versus HIV-uninfected adolescents in the United States. Mullins TL, Wilson CM, Rudy BJ, Sucharew H, Kahn JA. Sex Transm Dis; 2013 Sep 06; 40(9):715-20. PubMed ID: 23949587 [Abstract] [Full Text] [Related]
18. Anal and penile high-risk human papillomavirus prevalence in HIV-negative and HIV-infected MSM. van Aar F, Mooij SH, van der Sande MA, Speksnijder AG, Stolte IG, Meijer CJ, Verhagen DW, King AJ, de Vries HJ, Schim van der Loeff MF. AIDS; 2013 Nov 28; 27(18):2921-31. PubMed ID: 23921617 [Abstract] [Full Text] [Related]
19. Anal human papillomavirus DNA screening by Hybrid Capture II in human immunodeficiency virus-positive patients with or without anal intercourse. Drobacheff C, Dupont P, Mougin C, Bourezane Y, Challier B, Fantoli M, Bettinger D, Laurent R. Eur J Dermatol; 2003 Nov 28; 13(4):367-71. PubMed ID: 12948917 [Abstract] [Full Text] [Related]